Exclusive

Exclusive Bob Herman

STAT Plus: Hospital giant Ascension recorded about $1.3 billion in losses from its cyberattack

Exclusive Ed Silverman and Michael Nolan

STAT Plus: Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Top staffer on drug pricing to depart Senate Finance Committee

Exclusive Kate Raphael

Pediatricians’ obesity guidelines rest on shaky evidence about eating disorder risks

Exclusive Matthew Herper

STAT Plus: Former Verily executives hatch plan to invest millions in high-tech medical data

Exclusive Allison DeAngelis

STAT Plus: Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance

Exclusive Bob Herman

STAT Plus: Centene eliminates brokers’ commissions for Medicare drug plans

Exclusive Jason Mast

STAT Plus: Biden administration’s $3.2 billion antiviral pandemic plan is fizzling out

Exclusive Jason Mast and Allison DeAngelis

STAT Plus: Tome Biosciences, once a high-flying gene-editing startup, is floundering

Exclusive Mario Aguilar

STAT Plus: Digital therapeutics pioneer Pear’s treatments get a second life, a year after bankruptcy

Exclusive Meghana Keshavan

STAT Plus: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy

Exclusive Rachel Cohrs Zhang

STAT Plus: Former Biden White House health official joins Flagship Pioneering

Exclusive Elizabeth Cohen

STAT Plus: ‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers

Exclusive Allison DeAngelis

STAT Plus: Biotech VCs are pacing for another record-low year of fundraising amid glimpses of recovery

Exclusive Adam Feuerstein

STAT Plus: Sarepta demanded Duchenne patient advocacy group censor video critical of the company

Exclusive Megan Molteni

STAT Plus: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub

Exclusive Timmy Broderick

STAT Plus: Key disability civil rights law will get a big refresh under Sen. Bob Casey’s new bill

Exclusive Lizzy Lawrence

STAT Plus: Jeff Shuren, medical devices head at FDA, to leave the agency

Exclusive Timmy Broderick

STAT Plus: Wastewater surveillance group funded by Google founder, Bloomberg sheds dozens of testing sites

Exclusive Megan Molteni

STAT Plus: Broad Institute, facing end of Microsoft cloud contract, shuffles data science leadership

Exclusive Mohana Ravindranath

STAT Plus: Startup Q Bio raises $27 million to build its own full-body scanner

Exclusive Nicholas Florko

STAT Plus: Applesauce lead contamination could not have been prevented, top FDA official suggests

Exclusive Mohana Ravindranath

STAT Plus: A cancer care startup is making a new bet with payers and providers: only pay if it works

Exclusive Nicholas Florko

STAT Plus: Top FDA officials weighing regulation of ultra-processed foods, internal documents show

Exclusive Nicholas Florko and J. Emory Parker

STAT Plus: AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors

Exclusive Brittany Trang and Mohana Ravindranath

STAT Plus: Top Biden administration officials withdraw from Coalition for Health AI

Exclusive Allison DeAngelis

STAT Plus: Biotech accelerator Curie.Bio extends its reach with new $380 million fund

D.C. Diagnosis Sarah Owermohle

STAT Plus: Senators push Medicare for a PET scan pay bump

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests